Page 244 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 244

PP-61


               SWITCHER:  A  novel  tool  for  precise  ev  subpopulation  isolation  and

               nondestructive release with the SHINER workflow


                                                                                    ,1
                                                                  1
                                               1
               Jhih-Fong Li,  Chen-Wei Hsu,  Yao-Ching Fang,  Chi-An Cheng*
                             #,1

               1  School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
               * E-mail: cacheng123@ntu.edu.tw

               Abstract
                  Extracellular  vesicles  (EVs)  have  gained  attention  in  disease  diagnosis  and  therapeutic
               applications  due  to  their  diverse  roles  in  cellular  communication.  However,  their  natural
               variability poses a challenge, limiting their full potential. Traditional EV isolation methods
               typically  rely  on  biophysical  characteristics,  making  it  difficult  to  efficiently  separate  EV
               subpopulations based on molecular markers. Even affinity-based methods, which can target
               specific EV subtypes, often involve harsh recovery steps that can damage the EVs. To overcome
               these challenges, we present SHINER, a new approach to EV isolation and recovery. Central to
               SHINER  is  the  innovative  SWITCHER  tool,  which  works  in  combination  with  the
               ultrasensitive eSimoa platform we previously developed. SHINER achieves two key objectives:
               (1) the precise separation and gentle retrieval of specific EV subpopulations from complex
               biological  samples,  and  (2)  the  preservation  of  the  structural  integrity  and  biological
               functionality of the recovered EVs. SHINER enhances the ability to trace the origins of EVs
               for diagnostic purposes, opens new avenues in EV research, and provides standardized EVs for
               therapeutic applications. This breakthrough not only advances our understanding of EV biology
               but also paves the way for personalized diagnostic and treatment strategies, pushing the field
               of EV research to new heights.

               Keywords:  Extracellular  Vesicles  (EVs); Affinity-Based  Isolation;  CD81-Rich  EVs;  Single
                           Molecule Array (eSimoa)
   239   240   241   242   243   244   245   246   247   248   249